Boehringer Ingelheim has announced that Dr Wolfgang Baiker, U.S. Country Managing Director, President and CEO, will retire after 31 years of service to the company on July 31, 2020. Dr Jean-Michel Boers has been appointed to succeed him as Country Managing Director, President & CEO. 
.
Dr Boers, currently President of Boehringer Ingelheim Pharmaceuticals Inc., is responsible for the U.S. commercial and medical organization, ensuring the successful development of the company's current primary and specialty care portfolio, and preparing for future launches.
He joined Boehringer Ingelheim in 1998 in Belgium, and advanced through various roles in corporate and operating units, including Corporate Vice President, Marketing and Sales Effectiveness, Country Managing Director for France, and Human Pharma head of a European region consisting of mid-sized countries. 

Jean-Michel Boers will succeed Dr. Wolfgang Baiker, who will retire after 31 years of service at Boehringer Ingelheim.